One Nucleus is pleased to announce the shortlist for the One Nucleus Awards 2026.

The One Nucleus Award categories are structured to reflect that breadth of R&D, investment, service provision, and enabling support across the stakeholders.

Best Preclinical Stage R&D of the Year:
⭐ Axiom Therapeutics
⭐ LinkGevity
⭐ Immutrin
⭐C-Further
⭐Asgard Therapeutics

Best Clinical Stage R&D of the Year:
⭐ CellCentric
⭐ Alchemab Therapeutics Ltd
⭐ Hemab Therapeutics
⭐ Muna Therapeutics
⭐ Resolution Therapeutics

Best Use of Emerging Technology of the Year:
⭐ deepmirror
⭐ Luvida
⭐ ExpressionEdits
⭐ Unravel Health
⭐ Orbis Medicines

Best Non-Therapeutic R&D Company of the Year:
⭐ Profionics
⭐ Cizzle Bio, Inc.
⭐ VUGENE
⭐ MatriQx
⭐ Sano Genetics

Best Industry-Academia Deal of the Year:
⭐ GSK
⭐ Myricx Bio & Novartis
⭐ eXmoor Pharma & UCL
⭐ Lonza & UCL
⭐ Houdini Bio

Thank you to everyone who entered and congratulations to all the finalists. We wish you all good luck and look forward to celebrating with you on 10 December.

A special thank you to all the judges for your support.

For more information about the event, please visit:  https://www.onenucleusawards.com/